Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_assertion type Assertion NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_head.
- NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_assertion wasGeneratedBy ECO_0000203 NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_provenance.
- NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_assertion wasDerivedFrom befree-2016 NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_provenance.
- NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_assertion SIO_000772 22351748 NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_provenance.
- NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_assertion evidence source_evidence_literature NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_provenance.
- NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_assertion description "[Only 5 (23.8%) of the 21 HER2-positive breast tumors showed cdr2 immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962310.RAem8E_wJWSULNCnj2wX4HUgT20dljOWxfCt6ubAcq3Lg130_provenance.